Claire Mazumdar

Chief Executive Officer

Claire Mazumdar (Chief Executive Officer) filed 9 Form 4 reports in the trailing twelve months (0 purchases, 9 sales), most often in Bicara Therapeutics Inc. (BCAX). The largest single filing was $776K of BCAX (41,163 sh × $18.86, as filed), executed Nov 24 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 9 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$3.8M

shares × price, as filed

Last traded

Aug 10

Filed Aug 12

Median ADV $19.3M across their filed names

Open performance→

Volume by month

Buys $0 Sells $3.8M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 9 filings

Sector per market data · by filing · past 12 months

Most traded names

BCAX

Bicara Therapeutics Inc. BCAX · 0 buys · 9 sells 9 filings

Recent filings

BCAXSALE Bicara Therapeutics Inc. View filing → $280K
10,000 sh × $27.98
Exec Aug 10
Filed Aug 12 · 4:19 PM ET BCAXSALE Bicara Therapeutics Inc. View filing → $283K
9,972 sh × $28.42
Exec Jul 10
Filed Jul 14 · 4:22 PM ET BCAXSALE Bicara Therapeutics Inc. View filing → $240K
12,022 sh × $19.96
Exec May 18
Filed May 20 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. View filing → $354K
15,000 sh × $23.61
Exec Apr 20
Filed Apr 20 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. View filing → $252K
13,404 sh across 2 lots
Exec Mar 18
Filed Mar 20 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. View filing → $705K
36,766 sh × $19.17
Exec Mar 9
Filed Mar 11 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. View filing → $776K
41,163 sh × $18.86
Exec Nov 24 2025
Filed Nov 25 2025 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. View filing → $454K
24,103 sh × $18.83
Exec Oct 16 2025
Filed Oct 20 2025 · 5:30 PM ET More filings →